£66.99

It has never been this cheap. We have no record of a lower price.

£67 today · cheaper than every other day in the last 3 months

Diagnosis and treatment of acute lymphoblastic leukemia

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 55 days · 55 data points (no recent data)

Historical
Generating forecast…
£67.00 £66.99 £66.99 £66.99 £67.00 £67.00 £67.00 25 July 2026 07 August 2026 21 August 2026 03 September 2026 17 September 2026
View at Amazon ↗

Price data last checked 36 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 55 days • 1 price levels

Days at Price
55 days 0 14 28 41 55 £67 Days at Price

Price Analysis

Most common price: £67 (55 days, 100.0%)

Price range: £67 - £67

Price levels: 1 different prices over 55 days

Description

Significant progress has been made in the treatment of ALL in children. In adults, however, results are still unsatisfactory. Our results are less encouraging. Aim: To evaluate the results of the GRAALL and GRAAPH protocols in the treatment of adult ALL and to propose a therapeutic algorithm adapted to the prognostic factors validated in our patients. Methods: Our study was retrospective. It included adults treated for ALL diagnosed at the Haematology Department of the Hédi Chaker University Hospital in Sfax. We studied the diagnostic characteristics, therapeutic results, evolution and prognostic factors of our population. Results and Discussion: We enrolled 49 patients, with a sex ratio of 0.88. The median age was 42 years. Hyperleukocytosis >30 G/l was observed in 28% of cases. LAL-B was found in 65% of cases, LAL-T in 33% and biphenotypic in 2%. Karyotyping was conclusive in 70% of cases, 54% of which had cytogenetic abnormalities. The overall CR rate was 93% for non-phi+ ALL and 90% for phi+ ALL, with failure rates of 5% and 10% respectively.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
15 October 2024
Listed Since
16 October 2024

Barcode

No barcode data available

Similar Products You Might Like

Chronic lymphocytic leukaemia:: new diagnostic and therapeutic advances
99% match

Chronic lymphocytic leukaemia:: new diagnostic and therapeutic advances

£52.00 22 Sep 2026
Myelodysplastic syndromes: Clinical, biological, prognostic and therapeutic aspects
98% match

Myelodysplastic syndromes: Clinical, biological, prognostic and therapeutic aspects

£68.00 11 Sep 2026
LOMBARY DEGENERATIVE DISCOPATHY: Diagnosis & Treatment
98% match

LOMBARY DEGENERATIVE DISCOPATHY: Diagnosis & Treatment

£59.00 11 Sep 2026
Complement and antibodies in cancer: Research results
98% match

Complement and antibodies in cancer: Research results

£68.00 13 Sep 2026
Management of university academic offerings: And economic development
98% match

Management of university academic offerings: And economic development

£73.85 22 Sep 2026
Das Mikroumfeld von Stammzellen und seine Auswirkungen auf die Behandlung von Leukämie
98% match

Das Mikroumfeld von Stammzellen und seine Auswirkungen auf die Behandlung von Leukämie

£66.00 03 Oct 2026
CREATIVITY & BUSINESS DEVELOPMENT: Making creativity the key to business development
98% match

CREATIVITY & BUSINESS DEVELOPMENT: Making creativity the key to business development

£52.00 19 Sep 2026
Didactic strategies for training: A teaching experience
98% match

Didactic strategies for training: A teaching experience

£51.00 22 Sep 2026
Multidisciplinary Management of ENT Cancers
98% match

Multidisciplinary Management of ENT Cancers

£62.00 17 Sep 2026
Rapid diagnosis with staining: Smears and stains
98% match

Rapid diagnosis with staining: Smears and stains

£70.00 18 Sep 2026
Exogenous-organic brain disease in adolescents: Clinical and epidemiological study
98% match

Exogenous-organic brain disease in adolescents: Clinical and epidemiological study

£51.00 22 Sep 2026
Costing, pricing and hospital financing
98% match

Costing, pricing and hospital financing

£73.00 24 Sep 2026
PRESCHOOL PEDAGOGY: TEACHING AIDS
98% match

PRESCHOOL PEDAGOGY: TEACHING AIDS

£75.00 22 Sep 2026
Modeling and Simulation of Complex Systems
98% match

Modeling and Simulation of Complex Systems

£64.51 12 Sep 2026
THERAPEUTIC BIONANOCOMPOSITES: Fifth Edition
98% match

THERAPEUTIC BIONANOCOMPOSITES: Fifth Edition

£58.00 01 Oct 2026
Scientific-research competence in education: Education research
98% match

Scientific-research competence in education: Education research

£66.00 11 Sep 2026
Emotional intelligence, anxiety and performance: A dynamic approach to physical education and sports
98% match

Emotional intelligence, anxiety and performance: A dynamic approach to physical education and sports

£55.00 23 Sep 2026
Algorithmic logic
98% match

Algorithmic logic

£54.00 23 Sep 2026
Drug chemistry and therapeutic innovations
98% match

Drug chemistry and therapeutic innovations

£52.42 30 Sep 2026
Essential Computing: Fundamentals of Systems Development
98% match

Essential Computing: Fundamentals of Systems Development

£138.59 30 Sep 2026
Know thyself: synergy and antagonism of cells
98% match

Know thyself: synergy and antagonism of cells

£80.98 18 Sep 2026
Scientific knowledge and reasoning in schoolchildren: The case of Rwanda
98% match

Scientific knowledge and reasoning in schoolchildren: The case of Rwanda

£97.00 24 Sep 2026
Biotherapy and fatigue in rheumatoid arthritis
98% match

Biotherapy and fatigue in rheumatoid arthritis

£52.00 17 Sep 2026
Science, communication and action: Synergies
98% match

Science, communication and action: Synergies

£51.00 23 Sep 2026